Dr. Beata Anna Bajgierowicz, MD

Dr. Bajgierowicz practices at Central Maine Medical Center in Lewiston, Maine, part of Prime Healthcare Services.

Dr. Bajgierowicz's NPI, 1093012726, was assigned on February 15, 2011. Dr. Bajgierowicz holds Maine license MD21215.

Dr. Bajgierowicz's primary practice is Central Maine Medical Center, at 300 Main Street, Lewiston, ME 04240 in Androscoggin County. The practice phone is (207) 795-0111.

Dr. Bajgierowicz's primary practice is Central Maine Medical Center in Lewiston, Maine, part of Prime Healthcare Services. Dr. Bajgierowicz is also affiliated with Northern Light Eastern Maine Medical Center. The medical group on file is Central Maine Medical Center. Dmand AI also links Dr. Bajgierowicz to 4 more hospitals, 6 medical groups and 1 group practice or clinic, each named with a free account. Dr. Bajgierowicz's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bajgierowicz practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Bajgierowicz's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Bajgierowicz is licensed in Maine.

CMS data shows 1,536 Medicare services from Dr. Bajgierowicz across 16 procedure codes in 2024, for 847 Medicare patients. Medicare paid $50,460 for them.

CMS counts 847 Medicare patients who saw Dr. Bajgierowicz in 2024. The largest group is 65 to 74, with 273 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bajgierowicz's median patient age at 73, with 48% women.

In 2024, Dr. Bajgierowicz wrote 842 Medicare Part D claims for 196 patients. 81% of them were for generic drugs. CMS names the drug for 697 of them, across 20 drugs with 11 or more claims each, at $141,938 in total drug cost. In 2023, CMS named 446 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Bajgierowicz for performance year 2024, reported as part of a group. Dr. Bajgierowicz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 30 general payments to Dr. Bajgierowicz from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Boston Scientific Corporation paid the most, $124.